Biology & biomedicineA new targeted nanosystem improves brain drug delivery for the treatment after a stroke
- Details
- Category: Projects
-
18 Feb 2022
Direct brain administration through the carotid artery of nanomaterials carrying drugs after a stroke could be an effective method to reduce the undesirable effects in other organs, improving at the same time the arrival of the drug into the brain. A study has tested nanocapsules designed by scientists at the ICMAB-CSIC to transport drug molecules to brain areas by a micro catheter.
A spin-off company will develop a monoclonal antibody to treat autoimmune diseases such as psoriasis
- Details
- Category: Success stories
-
29 Dec 2021
The antibody acts on the immune system to increase anti-inflammatory activity and attenuate inflammation. It will be developed by the Inhibitec Anticuerpos company, created by the scientists who created the technology at the CSIC and the University of Cantabria.
A molecular mechanism of the cardiac alternans, one of the causes of severe cardiac arrhythmia, has been identified
- Details
- Category: Projects
-
27 Apr 2021
An international project with participation of IIBB-CSIC has identified one of the molecular mechanisms that causes the so-called “cardiac alternans”, an alteration of the cardiac rhythm that can cause ventricular fibrillation and potentially lethal cardiac arrhythmia. This finding opens a new path to the development of pharmacological treatment.
Folding paper device for an early detection of infections in chronic wounds
- Details
- Category: Technological offers
-
25 Nov 2021
Scientists from the CSIC and from the UPC university have developed a ‘point-of-care’ device for an early detection of infections by means of analysing body fluids such as saliva or exudates from chronic wounds.
Bio-nanocellulose meshes improve hernia repair surgery
- Details
- Category: Success stories
-
20 Apr 2021
Researchers from the Institute of Materials Science of Barcelona (ICMAB-CSIC) and B. Braun Surgical, a leading manufacturer of medical devices for wound closure, have collaborated to develop a bio-based surgical mesh with this biomaterial. First results from an in vivo animal study yield promising outcomes.
